M
Michael Ganetsky
Researcher at Beth Israel Deaconess Medical Center
Publications - 29
Citations - 698
Michael Ganetsky is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Dabigatran & Warfarin. The author has an hindex of 12, co-authored 29 publications receiving 580 citations. Previous affiliations of Michael Ganetsky include Rhode Island Hospital & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Toxicity of energy drinks.
TL;DR: Although prior studies have examined the effects of caffeine in adolescents, energy drinks should be considered a novel exposure and urgent research on the safety of energy drink use in children and adolescents is mandates.
Journal ArticleDOI
Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant
TL;DR: Limited and mixed data exist for transfusion of factor VIIa and prothrombin complex concentrates; these therapies should be considered as well as dialysis, which will increase elimination in patients with life-threatening or closed-space bleeding due to dabigatran.
Journal ArticleDOI
Hemorrhagic Complications in Emergency Department Patients Who Are Receiving Dabigatran Compared With Warfarin
Russell E. Berger,Russell E. Berger,Steven D. Salhanick,Steven D. Salhanick,Maureen Chase,Maureen Chase,Michael Ganetsky,Michael Ganetsky +7 more
TL;DR: Patients with dabigatran-induced bleeding had a more benign clinical course with a shorter length of stay compared with patients with warfarin-induced bleed, and there were fewer intracranial hemorrhages in patients receiving dabig atran than warfarins.
Journal ArticleDOI
Risk of Intracranial Hemorrhage in Ground-level Fall With Antiplatelet or Anticoagulant Agents.
Michael Ganetsky,Gregory J. Lopez,Tara Coreanu,Victor Novack,Steven Horng,Nathan I. Shapiro,Kenneth A. Bauer +6 more
TL;DR: There is a low incidence of clinically significant tICH with a ground-level fall in head trauma in patients taking an anticoagulant or antiplatelet medication, which is unanticipated and counterintuitive as most literature and teaching suggests a higher rate with antICOagulants.
Journal ArticleDOI
Acute Amnestic Syndrome Associated with Fentanyl Overdose
Jed A. Barash,Michael Ganetsky,Katherine L. Boyle,Vinod Raman,Michael S. Toce,Scott Kaplan,Michael H. Lev,Jonathan L. Worth,Alfred DeMaria +8 more
TL;DR: Four additional cases of severe amnesia and medial temporal changes on magnetic resonance imaging after drug overdose are reported in patients from Massachusetts who tested positive for fentanyl.